Illumina drives genomic testing as standard of care in oncology through collaborative research presented at ASCO

/PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced some of its latest research being...

Related Keywords

United States ,Chicago ,Illinois ,American ,Nicole Berry ,Vivek Subbiah ,Shakti Ramkissoon ,Pratheesh Sathyan ,Phase Drug Development ,Prnewswire Illumina Inc ,Youtube ,Nasdaq ,Sarah Cannon Research Institute ,Linkedin ,Instagram ,Facebook ,American Society Of Clinical Oncology ,American Society ,Clinical Oncology ,Annual Meeting ,Early Phase Drug Development ,